Literature DB >> 28282751

A single bout of high-intensity interval exercise and work-matched moderate-intensity exercise has minimal effect on glucose tolerance and insulin sensitivity in 7- to 10-year-old boys.

Emma J Cockcroft1, Craig A Williams1, Sarah R Jackman2, Shikhar Bassi2, Neil Armstrong1, Alan R Barker1.   

Abstract

The purpose of this study was to assess the acute effect of high-intensity interval exercise (HIIE) and moderate-intensity exercise (MIE) on glucose tolerance, insulin sensitivity and fat oxidation in young boys. Eleven boys (8.8 ± 0.8 y) completed three conditions: 1) HIIE; 2) work-matched MIE; and 3) rest (CON) followed by an oral glucose tolerance test (OGTT) to determine glucose tolerance and insulin sensitivity (Cederholm index). Fat oxidation was measured following the OGTT using indirect calorimetry. There was no effect for condition on plasma [glucose] and [insulin] area under the curve (AUC) responses following the OGTT (P > 0.09). However, there was a "trend" for a condition effect for insulin sensitivity with a small increase after HIIE (P = 0.04, ES = 0.28, 9.7%) and MIE (P = 0.07, ES = 0.21, 6.5%) compared to CON. There was an increase in fat oxidation AUC following HIIE (P = 0.008, ES = 0.79, 38.9%) compared to CON, but with no differences between MIE and CON and HIIE and MIE (P > 0.13). In conclusion, 7- to 10-year-old boys may have limited scope to improve insulin sensitivity and glucose tolerance after a single bout of HIIE and MIE. However, fat oxidation is augmented after HIIE but not MIE.

Entities:  

Keywords:  Cardiometabolic health; children; fat oxidation; insulin resistance; physical activity

Mesh:

Substances:

Year:  2017        PMID: 28282751     DOI: 10.1080/02640414.2017.1287934

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  7 in total

Review 1.  Perspectives on high-intensity interval exercise for health promotion in children and adolescents.

Authors:  Bert Bond; Kathryn L Weston; Craig A Williams; Alan R Barker
Journal:  Open Access J Sports Med       Date:  2017-11-27

2.  Effects of 6-Weeks High-Intensity Interval Training in Schoolchildren with Insulin Resistance: Influence of Biological Maturation on Metabolic, Body Composition, Cardiovascular and Performance Non-responses.

Authors:  Cristian Alvarez; Rodrigo Ramírez-Campillo; Robinson Ramírez-Vélez; Mikel Izquierdo
Journal:  Front Physiol       Date:  2017-06-29       Impact factor: 4.566

3.  Increasing the Duration of Light Physical Activity Ameliorates Insulin Resistance Syndrome in Metabolically Healthy Obese Adults.

Authors:  Fatema Al-Rashed; Abdulwahab Alghaith; Rafaat Azim; Dawood AlMekhled; Reeby Thomas; Sardar Sindhu; Rasheed Ahmad
Journal:  Cells       Date:  2020-05-11       Impact factor: 6.600

Review 4.  Effects of High-Intensity Interval Training and Moderate-Intensity Continuous Training on Cardiometabolic Risk Factors in Overweight and Obesity Children and Adolescents: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Meng Cao; Yucheng Tang; Shu Li; Yu Zou
Journal:  Int J Environ Res Public Health       Date:  2021-11-12       Impact factor: 3.390

5.  Effects of High-Intensity Interval Training in School on the Physical Performance and Health of Children and Adolescents: A Systematic Review with Meta-Analysis.

Authors:  Nikolai Bauer; Billy Sperlich; Hans-Christer Holmberg; Florian A Engel
Journal:  Sports Med Open       Date:  2022-04-11

6.  Effect of Exercise Duration on Postprandial Glycaemic and Insulinaemic Responses in Adolescents.

Authors:  Karah J Dring; Simon B Cooper; Ryan A Williams; John G Morris; Caroline Sunderland; Mary E Nevill
Journal:  Nutrients       Date:  2020-03-12       Impact factor: 5.717

7.  The effects of two weeks high-intensity interval training on fasting glucose, glucose tolerance and insulin resistance in adolescent boys: a pilot study.

Authors:  Emma J Cockcroft; Bert Bond; Craig A Williams; Sam Harris; Sarah R Jackman; Neil Armstrong; Alan R Barker
Journal:  BMC Sports Sci Med Rehabil       Date:  2019-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.